OLD Mission Capital LLC Invests $1.60 Million in Smith & Nephew plc (NYSE:SNN)

OLD Mission Capital LLC acquired a new stake in shares of Smith & Nephew plc (NYSE:SNN - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 65,023 shares of the medical equipment provider's stock, valued at approximately $1,598,000.

Other hedge funds also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. grew its position in Smith & Nephew by 29.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 27,199 shares of the medical equipment provider's stock worth $847,000 after purchasing an additional 6,164 shares in the last quarter. Citigroup Inc. lifted its position in shares of Smith & Nephew by 18.5% in the 3rd quarter. Citigroup Inc. now owns 119,215 shares of the medical equipment provider's stock worth $3,712,000 after acquiring an additional 18,630 shares during the period. Cerity Partners LLC boosted its stake in Smith & Nephew by 31.5% during the third quarter. Cerity Partners LLC now owns 19,001 shares of the medical equipment provider's stock worth $592,000 after buying an additional 4,552 shares in the last quarter. Townsquare Capital LLC increased its stake in Smith & Nephew by 5.4% in the third quarter. Townsquare Capital LLC now owns 14,759 shares of the medical equipment provider's stock valued at $460,000 after acquiring an additional 761 shares during the period. Finally, Atom Investors LP bought a new position in shares of Smith & Nephew during the 3rd quarter worth approximately $400,000. Institutional investors and hedge funds own 25.64% of the company's stock.

Smith & Nephew Trading Down 4.1 %

NYSE:SNN traded down $1.08 during mid-day trading on Monday, hitting $25.23. The company had a trading volume of 1,055,962 shares, compared to its average volume of 816,329. The firm has a market cap of $11.03 billion, a P/E ratio of 11.65, a P/E/G ratio of 1.26 and a beta of 0.71. Smith & Nephew plc has a fifty-two week low of $23.65 and a fifty-two week high of $31.72. The business's fifty day moving average is $27.38 and its two-hundred day moving average is $26.81. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Smith & Nephew Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Friday, March 28th will be issued a $0.447 dividend. This is an increase from Smith & Nephew's previous semi-annual dividend of $0.29. This represents a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, March 28th. Smith & Nephew's dividend payout ratio is 41.20%.

Analysts Set New Price Targets

Several brokerages have weighed in on SNN. StockNews.com raised shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research note on Wednesday, February 26th. UBS Group lowered shares of Smith & Nephew from a "buy" rating to a "neutral" rating in a research report on Wednesday, March 12th. Finally, Canaccord Genuity Group reissued a "hold" rating and issued a $27.00 price target on shares of Smith & Nephew in a report on Monday, March 17th. Four analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $27.00.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.